Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Seattle Genetics and Genentech expand antibody-drug conjugate agreement

Aug. 4, 2010

Lexicon reacquires rights to several serotonin synthesis inhibitors from Symphony Icon

Aug. 4, 2010

Cornerstone and Alitair collaborate on drug development for respiratory diseases

Aug. 4, 2010

Servier to develop and commercialize Osteologix's NBS-101 outside U.S.

Aug. 3, 2010

Stellar Pharma and Inibsa sign agreement to distribute and sell Uracyst in Spain

Aug. 2, 2010

Actient Pharmaceuticals acquires six pharmaceuticals from UCB

Aug. 2, 2010

National Eye Institute awards Lpath grant to develop sonepcizumab for wet AMD

Aug. 2, 2010

Daiichi Sankyo and Kitasato Institute to form joint venture company

Aug. 2, 2010

Charles River Laboratories and WuXi PharmaTech terminate acquisition agreement

Aug. 2, 2010

GSK licenses new antibiotic for Gram-negative infections from Anacor

July 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...